Shrestha Sharma

Gurgaon, HR 122413, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications

Development of an Injectable Thermosensitive Chitosan-Based Hydrogel for Localized Rutin Delivery Optimized Using Box-Behnken Design.

Development of an Injectable Thermosensitive Chitosan-Based Hydrogel for Localized Rutin Delivery Optimized Using Box-Behnken Design.

Journal: Drug development and industrial pharmacy
Published: August 12, 2026

Plant-Derived Polyphenols in Cancer Therapy: Bridging Molecular Mechanisms and Bioavailability Toward Clinical Translation.

Plant-Derived Polyphenols in Cancer Therapy: Bridging Molecular Mechanisms and Bioavailability Toward Clinical Translation.

Journal: Pharmaceutics
Published: May 15, 2026

Calcineurin Inhibitors in Atopic Dermatitis: Balancing Tradition with Emerging Therapeutics.

Calcineurin Inhibitors in Atopic Dermatitis: Balancing Tradition with Emerging Therapeutics.

Journal: Medical sciences (Basel, Switzerland)
Published: April 22, 2026

Disrupting the Undruggable: Emerging Modalities for Targeting Protein-Protein Interactions in Oncology.

Disrupting the Undruggable: Emerging Modalities for Targeting Protein-Protein Interactions in Oncology.

Journal: Biology
Published: April 20, 2026

Optimization and development of lycopene-loaded hydrogel for breast cancer using Box-Behnken design.

Optimization and development of lycopene-loaded hydrogel for breast cancer using Box-Behnken design.

Journal: Journal of Asian natural products research
Published: April 09, 2026

Oral GLP-1-Based Therapeutics in the Obesity-Metabolic Syndrome-Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies.

Oral GLP-1-Based Therapeutics in the Obesity-Metabolic Syndrome-Diabetes Continuum: Translational Advances, Clinical Barriers, and Emerging Strategies.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 31, 2026

Naringenin-loaded, tween 80-coated chitosan nanoparticles: a promising therapeutic for streptozotocin induced cognitive deficit in mice.

Naringenin-loaded, tween 80-coated chitosan nanoparticles: a promising therapeutic for streptozotocin induced cognitive deficit in mice.

Journal: Drug development and industrial pharmacy
Published: July 23, 2025

Advances in Adoptive Cell Therapies in Cancer: From Mechanistic Breakthroughs to Clinical Frontiers and Overcoming Barriers.

Advances in Adoptive Cell Therapies in Cancer: From Mechanistic Breakthroughs to Clinical Frontiers and Overcoming Barriers.

Journal: Medical sciences (Basel, Switzerland)
Published: June 08, 2025

Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and GLP-1 RAs.

Repurposing Diabetes Therapies in CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and GLP-1 RAs.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 18, 2025

RNA-Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins.

RNA-Based Therapies for Neurodegenerative Diseases Targeting Pathogenic Proteins.

Journal: The European journal of neuroscience
Published: January 26, 2025

Tumor microenvironment as a target for developing anticancer hydrogels.

Tumor microenvironment as a target for developing anticancer hydrogels.

Journal: Drug development and industrial pharmacy
Published: January 20, 2025

Gastrointestinal adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the EudraVigilance and VigiAccess databases.

Gastrointestinal adverse events associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the EudraVigilance and VigiAccess databases.

Journal: Expert opinion on drug safety
Published: October 11, 2024
Showing 1-12 of 28

Last Updated: 09/26/2026